Jim Cramer Calls Abbott “One of the Most Reliable Healthcare Companies”

Abbott Laboratories (NYSE:ABT) is one of the stocks in Jim Cramer’s game plan for this week. Cramer called the stock “terrific,” as he said:

“We also get results from one of the most reliable healthcare companies, Abbott Labs. We’ve owned Abbott for the trust for almost ever, and I think it’s just terrific.”

Africa Studio/Shutterstock.com

Abbott Laboratories (NYSE:ABT) develops, manufactures, and sells healthcare products, including pharmaceuticals, diagnostics, nutritionals, and medical devices. Cramer discussed the company post-earnings during the July 17 episode and commented:

“Today, in an otherwise positive market, I was discouraged to get a mixed update from Abbott Labs, medical technology company that we’ve long owned for the Charitable Trust… I’d say two decades. When Abbott Labs reported this morning, the… results were perfectly solid. Management tightened their full-year earnings guidance rather than raising it while also taking down their organic sales growth forecast and their operating margin outlook.

While we acknowledge the potential of ABT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.

View Comments